These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18058808)

  • 1. 15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12-dependent tumor formation in Nu/Nu mice.
    Pham H; Eibl G; Vincenti R; Chong B; Tai HH; Slice LW
    Mol Carcinog; 2008 Jun; 47(6):466-77. PubMed ID: 18058808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
    Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
    Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
    Ding Y; Tong M; Liu S; Moscow JA; Tai HH
    Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
    Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
    Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
    Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
    Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer.
    Liu Z; Wang X; Lu Y; Du R; Luo G; Wang J; Zhai H; Zhang F; Wen Q; Wu K; Fan D
    Cancer Biol Ther; 2010 Oct; 10(8):780-7. PubMed ID: 20699658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
    Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
    Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.
    Lim SC; Cho H; Lee TB; Choi CH; Min YD; Kim SS; Kim KJ
    Yonsei Med J; 2010 Sep; 51(5):692-9. PubMed ID: 20635443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-aminosalicylic acid mediates expression of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase to suppress colorectal tumorigenesis.
    Miyoshi J; Yajima T; Shimamura K; Matsuoka K; Okamoto S; Higuchi H; Funakoshi S; Takaishi H; Hibi T
    Anticancer Res; 2012 Apr; 32(4):1193-202. PubMed ID: 22493349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin catabolic enzymes as tumor suppressors.
    Tai HH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation.
    Roberts HR; Smartt HJ; Greenhough A; Moore AE; Williams AC; Paraskeva C
    Carcinogenesis; 2011 Nov; 32(11):1741-7. PubMed ID: 21926111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
    Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ
    Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
    Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.
    Pham H; Chen M; Li A; King J; Angst E; Dawson DW; Park J; Reber HA; Hines OJ; Eibl G
    Pancreas; 2010 Apr; 39(3):332-9. PubMed ID: 19820419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenase.
    Yao B; Xu J; Harris RC; Zhang MZ
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F433-9. PubMed ID: 18057186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
    Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
    Mann JR; Backlund MG; Buchanan FG; Daikoku T; Holla VR; Rosenberg DW; Dey SK; DuBois RN
    Cancer Res; 2006 Jul; 66(13):6649-56. PubMed ID: 16818638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.